Cargando…
An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment
Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radica...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278686/ https://www.ncbi.nlm.nih.gov/pubmed/32344912 http://dx.doi.org/10.3390/antiox9050359 |
_version_ | 1783543388628320256 |
---|---|
author | Attia, Mohamed Essa, Ebtessam Ahmed Zaki, Randa Mohammed Elkordy, Amal Ali |
author_facet | Attia, Mohamed Essa, Ebtessam Ahmed Zaki, Randa Mohammed Elkordy, Amal Ali |
author_sort | Attia, Mohamed |
collection | PubMed |
description | Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radical-related diseases. However, most of these antioxidants have anticancer effects only if taken in large doses. Others show inadequate bioavailability due to their instability in the blood or having a hydrophilic nature that limits their permeation through the cell membrane. Therefore, entrapping antioxidants in liposomes may overcome these drawbacks as liposomes have the capability to accommodate both hydrophilic and hydrophobic compounds with a considerable stability. Additionally, liposomes have the capability to accumulate at the cancer tissue passively, due to their small sizes, with enhanced drug delivery. Additionally, liposomes can be engineered with targeting moieties to increase the delivery of chemotherapeutic agents to specific tumour cells with decreased accumulation in healthy tissues. Therefore, combined use of liposomes and antioxidants, with or without chemotherapeutic agents, is an attractive strategy to combat varies tumours. This mini review focuses on the liposomal delivery of selected antioxidants, namely ascorbic acid (AA) and alpha-lipoic acid (ALA). The contribution of these nanocarriers in enhancing the antioxidant effect of AA and ALA and consequently their anticancer potentials will be demonstrated. |
format | Online Article Text |
id | pubmed-7278686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72786862020-06-12 An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment Attia, Mohamed Essa, Ebtessam Ahmed Zaki, Randa Mohammed Elkordy, Amal Ali Antioxidants (Basel) Review Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radical-related diseases. However, most of these antioxidants have anticancer effects only if taken in large doses. Others show inadequate bioavailability due to their instability in the blood or having a hydrophilic nature that limits their permeation through the cell membrane. Therefore, entrapping antioxidants in liposomes may overcome these drawbacks as liposomes have the capability to accommodate both hydrophilic and hydrophobic compounds with a considerable stability. Additionally, liposomes have the capability to accumulate at the cancer tissue passively, due to their small sizes, with enhanced drug delivery. Additionally, liposomes can be engineered with targeting moieties to increase the delivery of chemotherapeutic agents to specific tumour cells with decreased accumulation in healthy tissues. Therefore, combined use of liposomes and antioxidants, with or without chemotherapeutic agents, is an attractive strategy to combat varies tumours. This mini review focuses on the liposomal delivery of selected antioxidants, namely ascorbic acid (AA) and alpha-lipoic acid (ALA). The contribution of these nanocarriers in enhancing the antioxidant effect of AA and ALA and consequently their anticancer potentials will be demonstrated. MDPI 2020-04-25 /pmc/articles/PMC7278686/ /pubmed/32344912 http://dx.doi.org/10.3390/antiox9050359 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Attia, Mohamed Essa, Ebtessam Ahmed Zaki, Randa Mohammed Elkordy, Amal Ali An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment |
title | An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment |
title_full | An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment |
title_fullStr | An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment |
title_full_unstemmed | An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment |
title_short | An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment |
title_sort | overview of the antioxidant effects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278686/ https://www.ncbi.nlm.nih.gov/pubmed/32344912 http://dx.doi.org/10.3390/antiox9050359 |
work_keys_str_mv | AT attiamohamed anoverviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT essaebtessamahmed anoverviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT zakirandamohammed anoverviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT elkordyamalali anoverviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT attiamohamed overviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT essaebtessamahmed overviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT zakirandamohammed overviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment AT elkordyamalali overviewoftheantioxidanteffectsofascorbicacidandalphalipoicacidinliposomalformsasadjuvantincancertreatment |